Literature DB >> 31626293

Physiological and pathological roles of LRRK2 in the nuclear envelope integrity.

Vered Shani1, Hazem Safory1, Raymonde Szargel1, Ninghan Wang2, Tsipora Cohen1, Fatimah Abd Elghani1, Haya Hamza1, Mor Savyon1, Inna Radzishevsky1, Lihi Shaulov1, Ruth Rott1, Kah-Leong Lim3, Christopher A Ross4, Rina Bandopadhyay5, Hui Zhang2, Simone Engelender1.   

Abstract

Mutations in LRRK2 cause autosomal dominant and sporadic Parkinson's disease, but the mechanisms involved in LRRK2 toxicity in PD are yet to be fully understood. We found that LRRK2 translocates to the nucleus by binding to seven in absentia homolog (SIAH-1), and in the nucleus it directly interacts with lamin A/C, independent of its kinase activity. LRRK2 knockdown caused nuclear lamina abnormalities and nuclear disruption. LRRK2 disease mutations mostly abolish the interaction with lamin A/C and, similar to LRRK2 knockdown, cause disorganization of lamin A/C and leakage of nuclear proteins. Dopaminergic neurons of LRRK2 G2019S transgenic and LRRK2 -/- mice display decreased circularity of the nuclear lamina and leakage of the nuclear protein 53BP1 to the cytosol. Dopaminergic nigral and cortical neurons of both LRRK2 G2019S and idiopathic PD patients exhibit abnormalities of the nuclear lamina. Our data indicate that LRRK2 plays an essential role in maintaining nuclear envelope integrity. Disruption of this function by disease mutations suggests a novel phosphorylation-independent loss-of-function mechanism that may synergize with other neurotoxic effects caused by LRRK2 mutations.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31626293      PMCID: PMC7335485          DOI: 10.1093/hmg/ddz245

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  66 in total

1.  Regulation of prelamin A but not lamin C by miR-9, a brain-specific microRNA.

Authors:  Hea-Jin Jung; Catherine Coffinier; Youngshik Choe; Anne P Beigneux; Brandon S J Davies; Shao H Yang; Richard H Barnes; Janet Hong; Tao Sun; Samuel J Pleasure; Stephen G Young; Loren G Fong
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

2.  Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies.

Authors:  Gaia Skibinski; Ken Nakamura; Mark R Cookson; Steven Finkbeiner
Journal:  J Neurosci       Date:  2014-01-08       Impact factor: 6.167

3.  S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding.

Authors:  Makoto R Hara; Nishant Agrawal; Sangwon F Kim; Matthew B Cascio; Masahiro Fujimuro; Yuji Ozeki; Masaaki Takahashi; Jaime H Cheah; Stephanie K Tankou; Lynda D Hester; Christopher D Ferris; S Diane Hayward; Solomon H Snyder; Akira Sawa
Journal:  Nat Cell Biol       Date:  2005-06-12       Impact factor: 28.824

4.  Protein composition of the intranuclear inclusions of FXTAS.

Authors:  C K Iwahashi; D H Yasui; H-J An; C M Greco; F Tassone; K Nannen; B Babineau; C B Lebrilla; R J Hagerman; P J Hagerman
Journal:  Brain       Date:  2005-10-24       Impact factor: 13.501

5.  Human iPSC-based modeling of late-onset disease via progerin-induced aging.

Authors:  Justine D Miller; Yosif M Ganat; Sarah Kishinevsky; Robert L Bowman; Becky Liu; Edmund Y Tu; Pankaj K Mandal; Elsa Vera; Jae-won Shim; Sonja Kriks; Tony Taldone; Noemi Fusaki; Mark J Tomishima; Dimitri Krainc; Teresa A Milner; Derrick J Rossi; Lorenz Studer
Journal:  Cell Stem Cell       Date:  2013-12-05       Impact factor: 24.633

6.  MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition.

Authors:  Matthew J Fell; Christian Mirescu; Kallol Basu; Boonlert Cheewatrakoolpong; Duane E DeMong; J Michael Ellis; Lynn A Hyde; Yinghui Lin; Carrie G Markgraf; Hong Mei; Michael Miller; Frederique M Poulet; Jack D Scott; Michelle D Smith; Zhizhang Yin; Xiaoping Zhou; Eric M Parker; Matthew E Kennedy; John A Morrow
Journal:  J Pharmacol Exp Ther       Date:  2015-09-25       Impact factor: 4.030

7.  Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice.

Authors:  Yulan Xiong; Stewart Neifert; Senthilkumar S Karuppagounder; Qinfang Liu; Jeannette N Stankowski; Byoung Dae Lee; Han Seok Ko; Yunjong Lee; Jonathan C Grima; Xiaobo Mao; Haisong Jiang; Sung-Ung Kang; Deborah A Swing; Lorraine Iacovitti; Lino Tessarollo; Ted M Dawson; Valina L Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-31       Impact factor: 11.205

8.  Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease.

Authors:  Esti Liani; Allon Eyal; Eyal Avraham; Revital Shemer; Raymonde Szargel; Daniela Berg; Antje Bornemann; Olaf Riess; Christopher A Ross; Ruth Rott; Simone Engelender
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-02       Impact factor: 11.205

9.  Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein.

Authors:  Raquel Pinho; Isabel Paiva; Kristina Gotovac Jercic; Luis Fonseca-Ornelas; Ellen Gerhardt; Christiane Fahlbusch; Paula Garcia-Esparcia; Cemil Kerimoglu; Maria A S Pavlou; Anna Villar-Piqué; Éva Szego; Tomás Lopes da Fonseca; Francesca Odoardi; Szabolcs Soeroes; Ana Cristina Rego; Wolfgang Fischle; Jens C Schwamborn; Thomas Meyer; Sebastian Kügler; Isidre Ferrer; Johannes Attems; André Fischer; Stefan Becker; Markus Zweckstetter; Fran Borovecki; Tiago F Outeiro
Journal:  Hum Mol Genet       Date:  2019-01-01       Impact factor: 6.150

10.  Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases.

Authors:  Martin Steger; Francesca Tonelli; Genta Ito; Paul Davies; Matthias Trost; Melanie Vetter; Stefanie Wachter; Esben Lorentzen; Graham Duddy; Stephen Wilson; Marco As Baptista; Brian K Fiske; Matthew J Fell; John A Morrow; Alastair D Reith; Dario R Alessi; Matthias Mann
Journal:  Elife       Date:  2016-01-29       Impact factor: 8.140

View more
  8 in total

Review 1.  A Nuclear Belt Fastens on Neural Cell Fate.

Authors:  Ivan Mestres; Judith Houtman; Federico Calegari; Tomohisa Toda
Journal:  Cells       Date:  2022-05-27       Impact factor: 7.666

2.  The mechanistic role of alpha-synuclein in the nucleus: impaired nuclear function caused by familial Parkinson's disease SNCA mutations.

Authors:  Vivian Chen; Malik Moncalvo; Dominic Tringali; Lidia Tagliafierro; Ahila Shriskanda; Ekaterina Ilich; Wendy Dong; Boris Kantor; Ornit Chiba-Falek
Journal:  Hum Mol Genet       Date:  2020-11-04       Impact factor: 6.150

Review 3.  "LRRK2: Autophagy and Lysosomal Activity".

Authors:  Marta Madureira; Natalie Connor-Robson; Richard Wade-Martins
Journal:  Front Neurosci       Date:  2020-05-25       Impact factor: 4.677

4.  Parkinson's disease-related Leucine-rich repeat kinase 2 modulates nuclear morphology and genomic stability in striatal projection neurons during aging.

Authors:  Xi Chen; Chengsong Xie; Wotu Tian; Lixin Sun; Wang Zheng; Sarah Hawes; Lisa Chang; Justin Kung; Jinhui Ding; Shengdi Chen; Weidong Le; Huaibin Cai
Journal:  Mol Neurodegener       Date:  2020-02-19       Impact factor: 14.195

5.  Pitx3 deficiency promotes age-dependent alterations in striatal medium spiny neurons.

Authors:  Xi Chen; Zhaofei Yang; Yaping Shao; Kunhyok Kim; Yuanyuan Wang; Ying Wang; Haifeng Wu; Xiaolan Xu; Weidong Le
Journal:  Front Aging Neurosci       Date:  2022-09-07       Impact factor: 5.702

Review 6.  Review of the epidemiology and variability of LRRK2 non-p.Gly2019Ser pathogenic mutations in Parkinson's disease.

Authors:  Paweł Turski; Iwona Chaberska; Piotr Szukało; Paulina Pyska; Łukasz Milanowski; Stanisław Szlufik; Monika Figura; Dorota Hoffman-Zacharska; Joanna Siuda; Dariusz Koziorowski
Journal:  Front Neurosci       Date:  2022-09-20       Impact factor: 5.152

Review 7.  Molecular Pathways Involved in LRRK2-Linked Parkinson's Disease: A Systematic Review.

Authors:  Ailyn Irvita Ravinther; Hemaniswarri Dewi Dewadas; Shi Ruo Tong; Chai Nien Foo; Yu-En Lin; Cheng-Ting Chien; Yang Mooi Lim
Journal:  Int J Mol Sci       Date:  2022-10-03       Impact factor: 6.208

8.  Development of a physiologically relevant and easily scalable LUHMES cell-based model of G2019S LRRK2-driven Parkinson's disease.

Authors:  Barbara Calamini; Nathalie Geyer; Nathalie Huss-Braun; Annie Bernhardt; Véronique Harsany; Pierrick Rival; May Cindhuchao; Dietmar Hoffmann; Sabine Gratzer
Journal:  Dis Model Mech       Date:  2021-06-11       Impact factor: 5.758

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.